Health News Releases

January 10, 2020 09:45

Serum Institute and Aragen Bioscience Announce Collaboration on Vaccine Development

Aragen Bioscience, Inc, a subsidiary unit of GVK BIO and one of the leading pre-clinical CRO specializing in monoclonal antibody and other large-molecule product development and Serum Institute of Ind

January 10, 2020 08:38

Boehringer Ingelheim Partners with Enleofen to Develop First-in-Class Anti-IL-11 Therapies for a Range of Fibrotic Diseases

Boehringer Ingelheim and Enleofen Bio Pte. Ltd. (Enleofen) announced today the acquisition of worldwide exclusive rights to Enleofen’s preclinical interleukin-11 (IL-11) platform by Boehringer Ingelhe

January 09, 2020 13:39

Covetrus Announces Changes to Senior Management Team

Covetrus™ (NASDAQ: CVET), a global leader in animal-health technology and services, today announced several changes to its senior management and regional leadership teams. Effective January 7, 2020

January 09, 2020 11:50

Patient Safety Movement Foundation Launches ifyouvebeenharmed Website

Now there’s a website for patients and families that have experienced harm from medical errors: ifyouvebeenharmed.org. Launched by the Patient Safety Movement Foundation (PSMF), the site provides reso

January 08, 2020 16:50

Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Corporation (NEC; TOKYO: 6701), a leader in IT and network

January 07, 2020 10:30

OncoSec Sends Letter to Shareholders Highlighting that Both Leading Independent Proxy Advisory Firms - ISS and Glass Lewis - Have Recommended That OncoSec Shareholders Vote “FOR” the CGP/Sirtex Transaction on the WHITE Proxy Card

OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today issued the following letter to its shareholders. Th

December 31, 2019 11:48

WELT Smart Belt Pro Wins CES 2020 Innovation Award

WELT, a digital healthcare company, won the Innovation Awards for its new product, Smart Belt Pro, at CES 2020, the world’s largest consumer appliance fair, which is held in January 2020. An update

December 27, 2019 09:41

Institutional Shareholder Services Inc. (“ISS”) Recommends OncoSec Shareholders Vote “FOR” the CGP/Sirtex Transaction

OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that Institutional Shareholder Services I

December 24, 2019 13:56

Invicro LLC Announces Dr. Matthew Silva as New Chief Executive Officer and Dr. Jack Hoppin is Named President of Konica Minolta Precision Medicine

Invicro LLC, a Konica Minolta company, today announces, Dr. Matthew Silva has been appointed as the new Chief Executive Officer. Dr. Silva will assume the day-to-day leadership responsibilities of the

December 23, 2019 11:00

OncoSec Responds to Alpha’s “Proposal”

OncoSec Medical Incorporated (NASDAQ:ONCS), (the “Company” or “OncoSec”) today issued the following response to the latest press release from Alpha Holdings, Inc. (Alpha): “Throughout its campaign

December 23, 2019 10:28

OncoSec Releases Presentation Spotlighting the Benefits of the Proposed CGP/Sirtex Transaction and Partnership

OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced the release of a detailed presentation hi

December 20, 2019 14:25

Masimo and Dräger Expand Licensing Agreement to Add Masimo Brain Monitoring and Capnography Technologies

Masimo (NASDAQ: MASI) and Dräger (OTCMKTS: DRWKF) announced today that they have expanded their partnership, whereby Dräger will integrate additional Masimo measurement technologies into Dräger’s fami

December 18, 2019 16:55

FerGene Appoints David Meek President and Chief Executive Officer

FerGene, a new gene therapy company launched by Ferring Pharmaceuticals and Blackstone Life Sciences in November, today announced the appointment of David Meek as President and Chief Executive Officer

December 18, 2019 13:45

Shandong Fontacea Announces License Agreement with Janssen to Develop and Commercialize Anti-IL17A Monoclonal Antibody

Shandong Fontacea Pharmaceutical Co. Ltd. (“Fontacea”) announced today that it has entered into an exclusive license, development and commercialization agreement with Janssen Biotech, Inc., to develop

December 17, 2019 15:57

Covetrus Announces Leadership Changes, Reaffirms 2019 Financial Guidance

Covetrus™ (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that Stuart B. Gleichenhaus has been named interim chief financial officer, effective December 16, 2

December 16, 2019 10:29

PCI Pharma Services Announces Major Investment to Expand Development and Manufacturing Capabilities at Tredegar, UK Site

PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, today announced it has begun an expansion of its Tredegar facility in Wales, UK to enha

December 13, 2019 13:47

OncoSec CEO Sends Letter to Fellow Shareholders

Daniel O’Connor, President, Director & CEO of OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today sent t

December 12, 2019 15:51

Seattle Genetics and Takeda Announce Additional Analyses of ADCETRIS® (Brentuximab Vedotin) ECHELON-1 and ECHELON-2 Phase 3 Clinical Trials at the 2019 ASH Annual Meeting

Seattle Genetics, Inc. (Nasdaq:SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced additional analyses of results from the ECHELON-1 and ECHELON-2 frontline phase 3 tri

December 11, 2019 17:03

Final results from the NuProtect study demonstrating efficacy of Nuwiq® (simoctocog alfa) in previously untreated patients (PUPs) presented at ASH 2019

Octapharma has announced today that the final results from the NuProtect study, the largest prospective study of a single factor VIII (FVIII) product in true PUPs with severe haemophilia A, were prese

December 11, 2019 16:13

Solasia Announces License and Capital Alliance for SP-04 (PledOx®) with Maruho

Solasia Pharma K.K. (TSE: 4597, Headquarters: Tokyo, Japan, President & CEO: Yoshihiro Arai, hereinafter “Solasia”) announced today that it has entered into an exclusive license agreement with Maruho

December 10, 2019 23:50

Panda Biotech Plans the Largest Industrial Hemp Processing Facility for Fiber and Cellulose in the United States

Dallas-based Panda Biotech today announced it is developing its first industrial hemp processing facility to produce high-quality, textile-grade fiber and premium cellulose. The “Panda High Plains Hem

December 10, 2019 17:13

PanTheryx Bovine Colostrum Recognized as GRAS

PanTheryx, a biotechnology company committed to realizing the potential of bovine colostrum-based therapies to address a wide range of health conditions, today announced that an independent expert pan

December 10, 2019 17:04

Takeda Demonstrates Its Long-Standing Commitment to Advancing Treatments for Rare Bleeding Disorders with Studies Highlighting Real-World Evidence and Investigational Gene Therapy at ASH 2019

Takeda Pharmaceutical Company Limited (TSE: 4502/NYSE:TAK) (“Takeda”), today presented nine hematology poster presentations at the 61st American Society of Hematology (ASH) Annual Meeting that undersc

December 10, 2019 11:45

OncoSec Releases Video Highlighting Why CGP/Sirtex Strategic Transaction Will Create Significant Shareholder Value

OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, released a video featuring its President and Chief Execut

December 09, 2019 17:47

Galderma Investigational Therapy Nemolizumab Granted FDA Breakthrough Therapy Designation for the Treatment of Patients Suffering from Prurigo Nodularis

Galderma today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to the investigational therapy nemolizumab for the treatment of pruritus associat

News by Region

News by Industry